In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss seasonal vaccination planning and survey findings on laboratory industry growth. Later, Leslie Donato, Ph.D., a clinical chemist at Mayo Clinic, shares how an innovative testing panel is improving the diagnosis of bile acid malabsorption.

• Survey highlights laboratory growth strategies (00:29): Discover where laboratory leaders are investing, the challenges shaping the industry, and the strategies organizations are adopting to achieve sustainable growth.
• Seasonal viruses and vaccination planning (05:29): Discover how to learn more about vaccination options for viruses that typically surge during the fall and winter.
• Diagnostics for chronic diarrhea (07:43): Hear how a novel test is improving diagnosis and advancing understanding of bile acid malabsorption.

Resources

• Survey reveals four strategies for laboratory growth
• Vaccine and immunization guidance from Mayo Clinic
• Testing Options for Patients with Chronic Diarrhea: A Focus on Bile Acid Malabsorption Webinar
• Bile acid malabsorption: A patient-centered approach to diagnose a common cause of chronic diarrhea
• The right testing for an underrecognized cause of chronic diarrhea

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss advancement in Alzheimer’s testing and practical uses of artificial intelligence (AI) in healthcare. Later, Dr. Pritt welcomes Chris Garcia, M.D., Mayo Clinic Laboratories’ chief digital innovation officer, to explore the evolving role of data in research and development.

• Innovative Alzheimer’s test gets FDA clearance (00:33): Dr. Morice shares how a strategic collaboration is enabling Mayo Clinic Laboratories to offer a newly FDA-cleared blood test for Alzheimer’s disease for adults with cognitive symptoms as young as 40.
• AI helping diagnose rare diseases (03:37): Dr. Pritt and Dr. Morice reflect on a recent article highlighting how AI is helping clinicians identify rare diseases.
• Data use in research and development (08:16): Dr. Garcia discusses how data, AI, and cross-disciplinary collaboration are advancing research and innovation in laboratory medicine.

Note: Information in this post was accurate at the time of its posting.

Resources

• C2N Diagnostics: FDA clears C2N Diagnostics’ PrecivityAD2® —First Alzheimer’s blood test for adults with cognitive symptoms as young as 40
• Wall Street Journal: AI is helping patients solve medical mysteries
• Answers From the Lab: Digital Advances: What's Next for Clinical Diagnostics?
• Answers From the Lab: Accelerating Research and Development With BioPharma Diagnostics

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss Protecting Access to Medicare Act (PAMA) reform and recent reports about the New World screwworm. Dr. Morice also shares insights on building an innovation strategy that delivers meaningful organizational value.

• PAMA reform update (00:40): Dr. Morice discusses the status of the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act and PAMA.
• Tracking the New World screwworm (02:24): Learn about recent cases of the New World screwworm, why this parasitic fly is problematic, and how sterile insects help contain it.
• Developing an innovation strategy that drives value (04:49): Discover lessons from Dr. Morice’s experience developing a strategic approach to innovation that delivers meaningful outcomes and impact.

Resources

• 4 steps to establishing a new approach to innovation